NJAAIS 2019 Annual Teaching Day

Long Branch, NJ US
September 13, 2019

Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion.

Accreditation
his activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and New Jersey Allergy, Asthma, and Immunology Society (NJAAIS). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists and allied healthcare providers in the field of allergy, asthma and immunology

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Be familiar with diagnosis and management of contact dermatitis.
  2. Recognize nasal polyps etiology and pathology as well as potential treatment approaches including biologics.
  3. Summarize immunodeficiency diagnosis and management, including genetic screening.
  4. Recognize different underlying etiologies and associated diseases in asthma, including fungal diseases.
  5. Follow current evidence-based research and guidelines in food allergy prevention and management.
  6. Realize the spectrum of different disorders in hypereosinophilia and to implement sound approaches in diagnosis and management.

 

Additional information
Disclosure: 

Disclosure Policy

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Marc Rothenberg, MD, PhD (Speaker)

Consultant:  Celgene, Shire, AstraZeneca, GlaxoSmithKline, Pulm-One, Spoon Guru, Clostrabio, Allakos, Teva

Equity Holder: Pulm One, Spoon Guru, Clostrabio

Grant/research funding:  National Institutes of Health
 

Jordan Orange, MD (Speaker)

Consultant: Shire,  Grifols

Author: Wolters Kluwer (Up to Date)

Advisory Board: ADMA Biologics

Marcella Aquino, MD (Speaker)

Independent contractor/Contracted research: Regeneron, Genentech, Baxter

 

Kathleen Buchheit, MD (Speaker)

Advisory Board/Honorarium: Regeneron, Genentech

 

Ruchi Gupta, MD (Speaker)

Consultant/Primary investigator: Thermo Fisher, Aimmune, DBV Technologies, Before Brands, Genentech

The following have nothing to disclose:

 

Jacqueline Ross, MD (Planner)
Lisa Barisciano, MD (Planner)

David Corry, MD (Speaker)

Lin Li, MD (Program Director)

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Course opens: 
09/13/2019
Course expires: 
09/13/2021
Event starts: 
09/13/2019 - 7:30am CDT
Event ends: 
09/13/2019 - 4:30pm CDT
Add to calendar: 
Rating: 
5
Ocean Place Hotel
1 Ocean Blvd
Long Branch, NJ 07740
United States

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Please login or create an account to take this course.